Pamlectabart
Product Specifications
Target
TNF
Related Pathways
Apoptosis
Purity
0.966
Bioactivity
Pamlectabart is a humanised antibody targeting TNFRSF17/BCMA, which can be used to synthesise the antibody-drug conjugate (ADC) Pamlectabart tismanitin for the study of multiple myeloma.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
